Autoreactive CD4+CD28- T cells and acute coronary syndromes [2]

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 27, Issue 3, 2007, Pages

  Zal, Behnam ^a   Baboonian, Christina ^a   Kaski, Juan Carlos ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN;

ACUTE CORONARY SYNDROME; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CD4+ T LYMPHOCYTE; DISEASE PREDISPOSITION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; LETTER; PRIORITY JOURNAL;

ANTIGENS, CD28; AUTORECEPTORS; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTE SUBSETS;

EID: 33847027692     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000254856.95617.38     Document Type: Letter

References (16)

1. Robertson AK, Hansson GK. T cells in atherogenesis. For better or worse. Arterioscler Thromb Vas Biol. 2006;26:2421-2432.
2. Liuzzo G, Kopecky SL, Frye FL, Fallon M, Maseri A, Goronzy JJ, Weyand CM. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation. 1999;100:2135.
3. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, Weyand CM. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation. 2000;101:2883.
4. Nakajima T, Goek O, Zhang X, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. De novo expression of killer immunoglobulin-like receptors and signalling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res. 2003;93:106.
5. Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation. 2002;105:570.
6. Schmidt D, Martens PB, Weyand CM, Goronzy JJ. The repertoire of CD4+ CD28- T cells in rheumatoid arthritis. Mol Med. 1996;5:608-618.
7. Vallejo AN, Brandes JC, Weyand CM, Gorozny JJ. Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. J Immunol. 1999;162:6572-6579.
8. - T cells in patients with acute coronary syndromes. Circulation. 2004;109:1230-1235.
9. Kleindienst R, Xu Q, Willeit J, Waldenberger FR, Weimann S, Wick G. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. An J Pathol. 1993;142:1927-1937.
10. George J, Shoenfeld Y, Afek A, Gilburd B, Keren P, Shaish A, KOpolovic J, Wick G, Harats D. Enhanced fatty acid formation in C57BL/6J mice by immunization with heat shock protein 65. Atheroscler Thromb Vasc Biol. 1999;19:505-510.
11. de Graaf R, Kloppenburg G, Kitslaar PJ, Bruggeman CA, Stassen F. Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4. Microbes Infect. 2006;7:1859-1865.
12. Warrington KJ, Vallejo AN, Weyand CM, Goronzy JJ. CD28 loss in senescent CD4+ T cells: reversal by IL-12 stimulation. Blood. 2003;101:3543-3540.
13. Bryl E, Vallejo AN, Weyand CM, Goronzy JJ. Down-regulation of CD28 expression by TNF-alpha. J immunol. 2001;167:3231-03238.
14. Rizzello V, Liuzzo G, Brugaletta S, Rebuzzi A, Biasucci LM, Crea F. Modulation of CD4(+)CD28null T lymphocytes by tumor necrosis factor-alpha blockade in patients with unstable angina. Circulation. 2006;113:2272-2277.
15. Pawlik A, Ostanek L, Brzosko I, Brzosko M, Masiuk M, Machalinski B, Szklarz BG. Therapy with infliximab decreases the CD4+CD28- T cell compartment in peripheral blood in patients with rheumatoid arthritis. Rheumatol Int. 2004;24:351-354.
16. Bryl E, Vallejo AN, Matteson EL, Witkowski JM, Weyand CM, Goronzy JJ. Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis. Arthritis Rheum. 2005;52:2996-3003.